Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06823583 · ClinicalTrials.gov registry record
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
A clinical trial of Ventricular Assist Device and Advanced Heart Failure, sponsored by Bryan Heart.
- Recruiting
- Registry status
- 10
- Enrollment target
- 2
- Study locations
NCT06823583: Recruiting study of Ventricular Assist Device and Advanced Heart Failure, sponsored by Bryan Heart.
NCT06823583 is a study of Ventricular Assist Device and Advanced Heart Failure that is actively recruiting participants, run by Bryan Heart. The registered enrollment target is 10 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06823583, a study of Ventricular Assist Device and Advanced Heart Failure, is actively recruiting participants, sponsored by Bryan Heart.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
There are a variety of educational documents available to help in a participant's decision for VAD implant, however there is little information available to potential participants to help understand areas of satisfaction and concern following a VAD implant as various time points. The investigators want to provide better patient care through increased education and awareness beyond surgical outcomes and contribute to patient understanding of "what to expect" following a VAD implant. The investigators have created an anticipatory guidance (AG) tool based upon previous responses recorded in a local program's database, from the Quality of Life with a Left Ventricular Assist Device (QoLVAD) questionnaire. This questionnaire has five different domains (physical, social, emotional, cognitive thinking and spiritual/well-being). Investigators have previously analyzed responses to determine common areas of satisfaction and concern at 3-, 6-, 12- and 24-months post-VAD implant to better understand quality of life when living with a VAD. Investigators have had both VAD clinicians and VAD patients initially evaluate the tool to determine accuracy and effectiveness of the anticipatory guidance (AG) tool.
Primary Outcome
Evaluate clinician perspectives of the Ventricular Assist Device Anticipatory Guidance Tool (VAD AG Tool) v5.0 for accuracy, by completing an evaluation where each item will be scored 1-4, as follows: 1 Not Relevant, 2 Somewhat Relevant, 3 Quite Relevant, 4 Highly Relevant
Conditions Studied
Study Locations (2)
Nebraska
- Bryan Heart - Lincoln
Wisconsin
- Advocate Aurora Health - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-08-17 |
| Est. Completion | 2026-12 |
What NCT06823583 shows while recruiting
NCT06823583 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 3 conditions, with Ventricular Assist Device appearing as the primary indexed condition, and to 0 interventions.
NCT06823583 reports a single indexed study location in Nebraska, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06823583 about?
NCT06823583 is a clinical study titled "Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool". There are a variety of educational documents available to help in a participant's decision for VAD implant, however there is little information available to potential participants to help understand areas of satisfaction and concern following a VAD implant as various time points. The investigators w...
What is the current status of trial NCT06823583?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-08-17. Estimated completion is 2026-12.
What conditions does trial NCT06823583 study?
This clinical trial studies the following conditions: Ventricular Assist Device, Advanced Heart Failure, Anticipatory Guidance.
Who is sponsoring clinical trial NCT06823583?
This trial is sponsored by Bryan Heart, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06823583 being conducted?
This trial has 2 study locations across Nebraska, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI